SNORD47

Summary

SNORD47 (small nucleolar RNA, C/D box 47, HGNC:10187) is a gene on chromosome 1q25.1.

Predicted to be involved in RNA processing. Predicted to be located in nucleolus.

Source: NCBI Gene 26802 — RefSeq curated summary.

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:10187
Approved symbol	SNORD47
Name	small nucleolar RNA, C/D box 47
Location	1q25.1
Locus type	RNA, small nucleolar
Status	Approved
Aliases	U47
Entrez	26802
RNAcentral	URS0000507EBE — snoRNA, 77 nt, 3 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 0

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

None — 0 exons

Expression profiles

Top tissues by expression

0 total, by Bgee expression score (0-100, higher = more expressed):

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

• SNORD47 inhibits glioma cell growth, proliferation, colony formation, invasion, and migration, induces G2-phase arrest in vivo and vitro. (PMID:28410200)

Cross-species orthologs

0 orthologs

Protein

Protein identifiers

Canonical reviewed UniProt: None (reviewed: )

All UniProt accessions (0):

RefSeq proteins (0): (*=MANE)

Domains & families (InterPro)

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 0 (showing top):

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

0 interactions, top by confidence:

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	0
Likely benign	0
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

0 predictions. Top by Δscore:

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1001615710 (1:173864655 C>A), RS1002607397 (1:173866052 A>C), RS1002617054 (1:173865916 A>G), RS1002649601 (1:173865510 C>T), RS1003069702 (1:173865815 G>A), RS1004116595 (1:173865707 T>A,C), RS1006508995 (1:173864095 A>G,T), RS1006837276 (1:173865207 A>AT), RS1009037298 (1:173866222 A>G), RS1011315612 (1:173866248 T>C), RS1011733118 (1:173865251 CCA>C), RS1012326934 (1:173864151 T>A), RS1012656431 (1:173865499 C>T), RS1016440963 (1:173864117 G>A), RS1016767712 (1:173865468 T>C,G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
alpha phellandrene	decreases expression	1
versicolorin A	decreases expression	1
jinfukang	affects cotreatment, decreases expression	1
Benzo(a)pyrene	increases methylation	1
Cisplatin	affects cotreatment, decreases expression	1
Estradiol	increases expression	1
Valproic Acid	decreases methylation	1
Particulate Matter	increases expression	1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.